Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2QL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PRKD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OBSCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PATZ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UFSP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD81 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LTB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTAG1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADTRP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDS5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on